Xenetic Biosciences Inc. (NASDAQ: XBIO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT XENETIC BIOSCIENCES INC.

Xenetic Biosciences Inc. (NASDAQ: XBIO)
Listen to this Section


$2.92
-0.0250 ( -0.85% ) 26.2K

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.

Market Data


Open $2.92
Previous Close $2.94
Volume 26.2K
Market Cap $6.41M
Day Range $2.51 - $2.98
52 Week Range $1.90 - $13.93
Shares Outstanding 2.29M
Change % -0.85%
Net Change ▼ -0.0250
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2012
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -77,500.00

Date Type Amount Purchased Purchaser
2023-12-08 Sale -2500.00 Logal Adam

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 13, 2025
10-q Quarterly Reports 44 Nov 12, 2025
def Proxies and info statements 18 Oct 31, 2025
ars Annual reports 1 Oct 31, 2025
8-k 8K-related 16 Oct 14, 2025
8-k 8K-related 14 Aug 13, 2025
10-q Quarterly Reports 44 Aug 12, 2025

Latest News